SKP.L Regulatory News (SKP)

1 May 2007 14:04

Skyepharma PLC01 May 2007 SKYEPHARMA TO PRESENT AT 2007 UBS GLOBAL GENERIC & SPECIALTY PHARMACEUTICALS CONFERENCE LONDON, UK, MAY 1, 2007-- SkyePharma PLC (LSE: SKP; NASDAQ: SKYE) todayannounces that the Company's Chief Executive Officer, Frank Condella, will makea presentation at 2007 UBS Global Generic & Specialty Pharmaceuticals Conferencein New York, USA. Mr Condella will deliver his presentation on Tuesday 8 May2007 at 4.30 p.m. (GMT). Investors may access a live webcast of the presentationat www.skyepharma.com under the Investor Relations tab. The presentation will bearchived for 3 months. For further information please contact: SkyePharma PLC+44 207 491 1777Frank Condella, Chief Executive OfficerKen Cunningham, Chief Operating OfficerPeter Grant, Finance Director Financial Dynamics+44 207 7831 3113David YatesDeborah Scott The Trout Group+ 1 617 583 1308Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops newformulations of known molecules to provide a clinical advantage and life-cycleextension. The Company has ten approved products in the areas of oral,inhalation and topical delivery that are marketed throughout the world byleading pharmaceutical companies. For more information, visitwww.skyepharma.com. This information is provided by RNS The company news service from the London Stock Exchange